Navigation Links
GenElute Minus EtBr Spin Column from Sigma-Aldrich

ProductsGenElute Minus EtBr Spin Column from Sigma-Aldrich
Company Sigma-Aldrich
Item GenElute Minus EtBr Spin Column
Price 
Description The GenElute™ Minus EtBr Spin Columns provide a rapid and simple method for recovering ethidium bromide (EtBr)-free DNA (100 bp to 10 kb) from stained agarose gels or EtBr containing solutions. The DNA band is excised from an agarose gel and loaded into the spin column. Embedded within the base of the column are a series of membranes and filters that hold agarose and ethidium bromide back while allowing DNA to selectively pass through the column into a collection tube during a 10 minute centrifugation. GenElute Minus EtBr Spin Columns eliminate the need for silica-based resins, DEAE, or toxic organic solvents such as phenol and chloroform. There is no melting, electroelution, or enzymatic digestion of the agarose gel. More than 95% of the ethidium bromide is typically removed from the agarose.
Info Sigma-AldrichSigma-Aldrich
Sigma-Aldrich Corp.
St. Louis, MO, USA
Customer Service: 800-325-3010
Tech Support: 800-325-5832
Fax Number: 314-771-5757
Web Site: http://www.sigmaaldrich.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GenElute Agarose Spin Columns from Sigma-Aldrich
2. GenElute Gel Extraction Kit from Sigma-Aldrich
3. Klenow Fragment, Exonuclease Minus from Promega
4. Amino Acid Mixture Minus Leucine from Promega
5. Amino Acid Mixture Minus Cysteine from Promega
6. Extracti-Gel D Detergent Removing Gel AffinityPak Columns from Pierce Biotechnology, Inc.
7. Freeze N Squeeze Spin Columns, 100 from Bio-Rad
8. Freeze N Squeeze Spin Columns, 25 from Bio-Rad
9. HV-2080-01 Column Switching Valve from JASCO
10. LS Columns from Miltenyi Biotec
11. Zeba Desalt Spin Columns, 2 mL., 25/Pkg. from Pierce Biotechnology, Inc.
Liquid. PBS containing 10 mM NaN 3 . AVOID FREEZE/THAW CYCLES. Recognizes α1, 2, 3, 5, 6 and 7 subunits of 20S proteasome. ...
Anti-TNKS2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
Rabbit Anti-Human Janus Kinase 2 (JAK2 Polyclonal Antibody Family: Protein Kinase Sub-Family: TYK2/JAK Applications: ELISA, Western Blot...
Goat polyclonal to Lipocalin 2...
Biology Products:
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... Societies for Experimental Biology (FASEB) announces the opening ... Mechanism and Regulation of Prokaryotic Transcription. ... and Regulation of Prokaryotic Transcription will convene Sunday, ... Transcription Meeting," first held in 1991, has emerged ...
... Since the mid-nineteenth century, maps have helped elucidate the ... Yet today,s global mapping of infectious diseases is considerably ... of potential outbreaks, according to a new systematic mapping ... humans., Of the 355 infectious diseases assessed in the ...
... every time a cell divides and replicates. Depending on ... Many proteins are involved in everyday DNA repair, but ... and cancer can occur. Cells have two complicated ways ... of the entire genome., Roger A. Greenberg, M.D., Ph.D., ...
Cached Biology News:Avoiding a cartography catastrophe 2Changes to DNA on-off switches affect cells' ability to repair breaks, respond to chemotherapy 2
(Date:5/21/2015)... (PRWEB) May 21, 2015 uBiome, ... announced a partnership with PicnicHealth, a healthcare company ... Participants diagnosed with Inflammatory Bowel Disease (IBD) will ... a complementary uBiome research kit. Both companies were ... , For more information on this ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... May 21, 2015 Tunnell Consulting, ... the firm as senior statistician and Principal, a position ... experience in the management and analysis of complex and ... chemical industries. , “We’re delighted to have Julia join ... data analytics,” said Dr. Philippe Cini, Group Vice President ...
(Date:5/20/2015)... Pa. , May 20, 2015  Select ... that the Federal Trade Commission granted early termination ... Antitrust Improvements Act of 1976, as amended, applicable ... MJ Acquisition Corporation, a joint venture that Select ... L.P. As previously announced, MJ Acquisition ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2